Deals Update
Executive Summary
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
You may also be interested in...
Food Importing Unlikely For USPlabs Owner's Future
FDA debars Matthew Hebert, USPlabs co-owner “with primarily responsibilities over product packaging design,” for five years from importing dietary ingredients or other articles of food.
Sanofi’s Dupixent Benefits In Chronic Spontaneous Urticaria Add To Strong Second Quarter
Sanofi’s sales grew strongly in the second quarter, driven by the immunologic Dupixent and its vaccines business, with the company also reporting success in a further potential indication for the product, chronic spontaneous urticaria. The big pharma has raised its EPS guidance for the year.
AstraZeneca’s Soriot Dismisses Any Pfizer Vaccine ‘Envy’ Amid Bouyant Q2 Results
The UK company has raised its forecasts for 2021 after a better-than-expected Q2, even though Vaxzevria remains a very mixed blessing.